2m 2m 2m 2m 2m 2m 2m
BENITEC BIOPHRM (BNTC)
NASDAQ
$10.40-$0.18 (-1.70%)
Price as of Jun 03, 2026 4:10 PM EDT- $397.1MMarket Cap
- -32.22%1-Year Change
- BiotechnologyIndustry
BENITEC BIOPHRM (BNTC)
$10.40-$0.18 (-1.70%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 +100.00% | -1,000 -66.67% | -3,000 -105.08% | 59,000 -42.16% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 +100.00% | -1,000 -66.67% | -3,000 -105.08% | 59,000 -42.16% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -18.3M +17.45% | -15.6M +22.19% | -12.8M +81.97% | -7.0M +133.92% | |
Depreciation and Amortization Expense | 66,000 -24.14% | 87,000 -36.03% | 136,000 -41.13% | 231,000 +21.58% | |
Total Operating Expenses | 41.8M +85.70% | 22.5M +17.40% | 19.2M +40.29% | 13.7M +62.89% | |
Operating Profit | -41.8M +85.70% | -22.5M +17.87% | -19.1M +40.34% | -13.6M +64.18% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -33,000 +450.00% | -6,000 N/A | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -33,000 +450.00% | -6,000 N/A | |
Total Nonoperating Income and Expense | 3.8M +420.70% | 739,000 +253.64% | -481,000 +68.18% | -286,000 -4,185.71% | |
Income before Taxes | -37.9M +69.50% | -22.4M +17.24% | -19.1M +40.34% | -13.6M +64.18% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -37.9M +74.32% | -21.8M +11.19% | -19.6M +40.92% | -13.9M +67.78% | |
Net Income from Continuing Operations Applicable to Common | -37.9M +69.50% | -22.4M +14.35% | -19.6M +40.92% | -13.9M +67.78% | |
Basic EPS and Net Income | -1.05 -80.94% | -5.51 -60.98% | -14.12 +337.15% | -3.23 -60.12% | |
Diluted EPS and Net Income | -1.05 -80.94% | -5.51 -60.98% | -14.12 +337.15% | -3.23 -60.12% | |
Basic Weighted Average Shares | 36.2M +791.81% | 4.1M +192.98% | 1.4M -67.74% | 4.3M +320.63% | |
Diluted Weighted Average Shares | 36.2M +791.81% | 4.1M +192.98% | 1.4M -67.74% | 4.3M +320.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 97.7M +92.16% | 50.9M +1,953.53% | 2.5M -87.47% | 19.8M +101.70% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 97.7M +92.16% | 50.9M +1,953.53% | 2.5M -87.47% | 19.8M +101.70% | |
Total Current Assets | 98.5M +90.65% | 51.7M +1,285.73% | 3.7M -81.91% | 20.6M +90.66% | |
Accumulated Depreciation | 1.5M +4.70% | 1.4M +6.53% | 1.3M +29.47% | 1.0M +27.89% | |
Property and Plant and Equipment and Net | 131,000 -26.82% | 179,000 +105.75% | 87,000 -76.80% | 375,000 +0.27% | |
Total Long-Term Assets | 131,000 -26.82% | 179,000 +105.75% | 87,000 -52.97% | 185,000 -50.53% | |
Total Assets | 99.6M +90.75% | 52.2M +1,069.58% | 4.5M -79.12% | 21.4M +84.51% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.8M -63.40% | 4.9M +23.78% | 4.0M +190.58% | 1.4M +20.51% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 495,000 N/A | 0 -100.00% | 284,000 +33.33% | 213,000 0.00% | |
Total Liabilities | 2.3M -53.71% | 5.0M +16.42% | 4.3M +211.32% | 1.4M +1.48% | |
Retained Earnings | -228.2M +19.93% | -190.3M +13.32% | -167.9M +29.03% | -130.1M +11.56% | |
Total Stockholders Equity | 97.3M +105.92% | 47.2M +23,290.10% | 202,000 -98.99% | 20.0M +95.45% | |
Total Shares Outstanding | 26.3M +1,470.49% | 1.7M +1.55% | 1.6M -79.86% | 8.2M +637.27% | |
Cash Flow | |||||
Cash from Operating Activities | -23.6M +21.57% | -19.4M +7.72% | -18.0M +40.37% | -12.8M +70.30% | |
Capital Expenditures | 18,000 -89.94% | 179,000 +17,800.00% | 1,000 -99.55% | 221,000 +132.63% | |
Cash from Investing Activities | -18,000 -89.94% | -179,000 +17,800.00% | -1,000 -99.55% | -221,000 +135.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 70.5M +3.61% | 68.0M +324.78% | 16.0M -28.89% | 22.5M +1,172.43% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | 2,249,000.00% N/A | N/A N/A | -23,044.07% N/A | |
Return on Assets | -49.96% -34.92% | -76.76% N/A | N/A N/A | -84.22% N/A | |
Return on Equity | -52.46% -42.77% | -91.68% N/A | N/A N/A | -91.79% N/A | |
Revenue Growth | 100.00% +50.00% | 66.67% N/A | N/A N/A | -42.16% N/A | |
Current Ratio | 54.67 +420.96% | 10.49 N/A | N/A N/A | 15.05 N/A | |
Cash Ratio | 54.24 +425.08% | 10.33 N/A | N/A N/A | 14.44 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow